title: Selective spinal anesthesia for inguinal herniorrhaphy.
abstract: OBJECTIVE
  To determine the characteristic profiles of 2 hypobaric spinal anesthetic solutions for selective spinal anesthesia in inguinal herniorrhaphy.
  
  
  METHODS
  The study took place in the general surgery room of Anesthesia Department, Ankara Numune Research and Training Hospital between May and July 2005 as a prospective, randomized and double-blind trial. Sixty-one ASA I-III patients scheduled for inguinal herniorrhaphy were randomly divided into 2 groups. Group R received combined spinal epidural anesthesia with ropivacaine 7.5 mg and group B received bupivacaine 5 mg; in both groups 25 ug of fentanyl was added. Solutions were diluted with 1.5 ml of sterile water. A Portex 18/27 or 16/27 needle was inserted at L1-2 or L2-3 with patients sitting upright; surgery began after the sensory block reached the T6 dermatome. Sensory and motor block characteristics, hemodynamic data, side effects, recovery time, the timing of the onset of pain, and the walkout were assessed.
  
  
  RESULTS
  Motor block duration was shorter in Group R (56.1 +/- 36.1 minutes versus 72.5 +/- 23.3 minutes) (p=0.013). Complete motor block duration was shorter in Group R. There was no difference between the 2 groups. Intra-group analysis showed that hemodynamic values after anesthesia induction were lower than initial values.
  
  
  CONCLUSIONS
  Ropivacaine plus fentanyl provided similar sensory anesthesia, but with a shorter duration of motor block than bupivacaine plus fentanyl when used for selective spinal anesthesia in herniorrhaphy surgery. Furthermore, we suggest that hemodynamic should be carefully monitored during surgery.
authors.affiliation: Department of Anesthesiology and Reanimation, Ankara Numune Training & Research Hospital, Ankara, Turkey.
authors.forename: Yasar
authors.initials: Y
authors.lastname: Pala
authors.forename: Murat
authors.initials: M
authors.lastname: Ozcan
authors.forename: Gulten
authors.initials: G
authors.lastname: Dikmeer
authors.forename: Vildan
authors.initials: V
authors.lastname: Taspinar
authors.forename: Dilsen
authors.initials: D
authors.lastname: Ornek
authors.forename: Levent
authors.initials: L
authors.lastname: Ozdogan
authors.forename: Aydin
authors.initials: A
authors.lastname: Selcuk
authors.forename: Bayazit
authors.initials: B
authors.lastname: Dikmen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000556:Ambulatory Surgical Procedures; D000577:Amides / Q000494:pharmacology*; D000775:Anesthesia, Spinal / Q000009:adverse effects / Q000379:methods*; D002045:Bupivacaine / Q000494:pharmacology*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005283:Fentanyl / Q000494:pharmacology*; D005500:Follow-Up Studies; D006552:Hernia, Inguinal / Q000175:diagnosis / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D009407:Nerve Block; D010149:Postoperative Pain / Q000503:physiopathology; D017060:Patient Satisfaction; D018579:Patient Selection; D011446:Prospective Studies; D018570:Risk Assessment; D000077212:Ropivacaine; D016896:Treatment Outcome; D014421:Turkey; D055815:Young Adult
chemical_list: D000577:Amides; D000077212:Ropivacaine; D005283:Fentanyl; D002045:Bupivacaine